JONES LANG LASALLE INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that JONES LANG LASALLE INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.12B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $23.43B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $20.76B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $20.86B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $19.37B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $16.59B | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $5.40B | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $4.50B | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $4.27B | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $3.82B | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $792.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $546.80M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $225.40M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $654.50M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $961.60M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $402.50M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $535.30M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $484.50M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $276.40M | Feb 27, 2020 |
| FY2014 | Dec 31, 2014 | $386.06M | Feb 27, 2015 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $868.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $576.50M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $868.10M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $1.04B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $559.10M | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $368.30M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $171.60M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $150.10M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $25.40M | Feb 27, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.19B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $785.30M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $575.80M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $199.90M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $972.40M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $1.11B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $483.80M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $604.10M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $798.70M | Feb 27, 2020 |
| FY2014 | Dec 31, 2014 | $498.86M | Feb 27, 2015 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $156.90M | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $110.80M | Feb 27, 2015 |
| FY2014 | Dec 31, 2012 | $95.50M | Feb 27, 2015 |
| FY2013 | Dec 31, 2011 | $92.17M | Feb 27, 2014 |
| FY2012 | Dec 31, 2010 | $48.47M | Feb 26, 2013 |
| FY2011 | Dec 31, 2009 | $45.49M | Feb 27, 2012 |
| FY2010 | Dec 31, 2008 | $103.70M | Feb 25, 2011 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.80B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $16.76B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $16.06B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $15.59B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $15.51B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $14.32B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $13.67B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $10.03B | Feb 27, 2020 |
| FY2014 | Dec 31, 2014 | $5.08B | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $4.60B | Feb 27, 2015 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.18B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $9.87B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $9.65B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $9.44B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $9.08B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $8.70B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $8.46B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $6.29B | Feb 27, 2020 |
| FY2014 | Dec 31, 2014 | $2.65B | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $2.41B | Feb 27, 2015 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.50B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.77B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $6.29B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $6.02B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $6.18B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $5.52B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $5.12B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $3.69B | Feb 27, 2020 |
| FY2014 | Dec 31, 2014 | $2.39B | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $2.18B | Feb 27, 2015 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.71B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $4.61B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $4.59B | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $4.53B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $4.61B | Feb 27, 2024 |
| FY2021 | Dec 31, 2020 | $4.22B | Feb 28, 2022 |
| FY2021 | Dec 31, 2019 | $4.17B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $2.70B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $2.71B | Feb 27, 2020 |
| FY2014 | Dec 31, 2014 | $1.91B | Feb 27, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.11B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.33B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $5.80B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $5.59B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $4.94B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $3.98B | Feb 28, 2022 |
| FY2020 | Jan 1, 2020 | $3.57B | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $3.59B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $3.10B | Feb 27, 2020 |
| FY2014 | Dec 31, 2014 | $1.63B | Feb 27, 2015 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $599.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $416.30M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $410.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $519.30M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $593.70M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $574.30M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $451.90M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $480.90M | Feb 27, 2020 |
| FY2014 | Dec 31, 2014 | $250.41M | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $152.73M | Feb 27, 2015 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $275.00M | Feb 27, 2015 |
| FY2013 | Dec 31, 2013 | $275.00M | Feb 27, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 11 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 13 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 18 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 7 | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | 5 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 2 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 11 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 13 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 18 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 7 | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | 5 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 2 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 46.95M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 47.42M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 47.51M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 47.51M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 50.02M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 51.11M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 51.55M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | 45.60M | Feb 27, 2020 |
| FY2014 | Dec 31, 2014 | 44.83M | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | 44.45M | Feb 27, 2015 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | Feb 28, 2022 |
| FY2021 | Dec 31, 2020 | $0 | Feb 28, 2022 |
| FY2021 | Dec 31, 2019 | $42.70M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $37.80M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $33.10M | Feb 27, 2020 |
| FY2014 | Dec 31, 2014 | $21.89M | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $20.03M | Feb 27, 2015 |
| FY2014 | Dec 31, 2012 | $18.22M | Feb 27, 2015 |
| FY2013 | Dec 31, 2011 | $13.48M | Feb 27, 2014 |
| FY2012 | Dec 31, 2010 | $8.96M | Feb 26, 2013 |